BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 66 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231 | -80.2% | 16,006 | -77.5% | 0.00% | -50.0% |
| Q2 2023 | $1,166 | -1.8% | 71,006 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $1,187 | +8.3% | 71,006 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $1,096 | -99.9% | 71,006 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,060,000 | +77.6% | 71,006 | +95.3% | 0.00% | +100.0% |
| Q2 2022 | $597,000 | -34.7% | 36,363 | -20.2% | 0.00% | -50.0% |
| Q1 2022 | $914,000 | +259.8% | 45,588 | +355.9% | 0.00% | – |
| Q4 2021 | $254,000 | -81.5% | 10,000 | -80.4% | 0.00% | -100.0% |
| Q3 2021 | $1,376,000 | -6.7% | 50,994 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,475,000 | -26.5% | 50,994 | -33.2% | 0.00% | -25.0% |
| Q1 2021 | $2,008,000 | -2.1% | 76,361 | +6.6% | 0.00% | -20.0% |
| Q4 2020 | $2,052,000 | +12.1% | 71,608 | -6.7% | 0.01% | 0.0% |
| Q3 2020 | $1,830,000 | +510.0% | 76,733 | +434.7% | 0.01% | +400.0% |
| Q2 2020 | $300,000 | – | 14,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |